Brief: Canbridge Pharmaceuticals Announces CAN 103 Included In China's Innovative Drug List
08/12/2025 15:26
Dec 8 (Reuters) - Canbridge Pharmaceuticals Inc 1228.HK: CAN 103 INCLUDED IN CHINA'S INNOVATIVE DRUG LIST Further company coverage: 1228.HK ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Canbridge Pharmaceuticals
See all newsCANbridge Pharmaceuticals jumps as WuXi Biologics buys shares
Brief: Canbridge Pharmaceuticals Inc To Issue Aggregate Of 84 Million Subscription Shares
Brief: Canbridge Pharmaceuticals Announces CAN 103 Included In China's Innovative Drug List
Brief: CANbridge Pharmaceuticals Inc To Issue 10 Million Shares At HK$2.26 Per Share
Brief: Canbridge Pharmaceuticals Announces Units Formalized Strategic Relationship